Myo-inositol During Pregnancy to Prevent Gestational Diabetes

Myo-inositol During Pregnancy to Prevent Gestational Diabetes

Recruiting N/A Interventional Study
Pregnancy Related
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
40 (estimated)
Sponsor
Tufts Medical Center · Other
Who this trial is looking for

This trial is looking for pregnant women who are overweight and want to prevent gestational diabetes. Participants will take either myo-inositol or a placebo and will monitor their blood sugar levels.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am pregnant with one baby.
  • I am between 18 and 45 years old.
  • I am in my first trimester, before 16 weeks of pregnancy.
  • I have a pre-pregnancy BMI of 30 or higher.
  • I am receiving care at Tufts Medical Center.
  • I plan to give birth at Tufts Medical Center.
  • I can tolerate a glucose tolerance test.
  • I am willing to use a continuous glucose monitor.

You may not be able to join if

  • I am pregnant with more than one baby.
  • I have diabetes before my pregnancy.
  • I take medications that affect my weight or metabolism.
  • I cannot tolerate a glucose tolerance test.
  • I am unable to consent due to cognitive impairment.
  • I am a ward of the state.
  • My baby is not viable.
  • My baby's viability is uncertain.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Myoinositol is an insulin-like compound that is present in both plant and animal cells. Humans synthesize it naturally, but it is also obtained in our diet. It works through an intracellular signaling pathway to increase insulin sensitivity. Myoinositol has been used as an over-the-counter (OTC) supplement in the management of polycystic ovarian syndrome due to this effect. Myoinositol has also be…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Singleton gestations Women aged \> 18 years and \< 45 years Recruited before 16 weeks gestation Obese (pre-pregnancy BMI ≥ 30) Receiving prenatal care at Tufts Medical Center Planning to give birth at Tufts Medical Center Can tolerate glucose tolerance test Willing and ab…
Contacts

Zeinab Kassem, MD

617-636-9897

zeinab.kassem@tuftsmedicine.org

CONTACT